APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-TNF-α Monoclonal Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-TNF-α Monoclonal Antibody Industry Growth and Trends Forecast to 2032

2 January 202673 pages

Choose your research edition.

Industry ResearchAnti-TNF-α Monoclonal Antibody Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-TNF-α Monoclonal Antibody Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Anti-TNF-α Monoclonal Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-TNF-α Monoclonal Antibody Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-TNF-α Monoclonal Antibody Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Anti-TNF-α Monoclonal Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-TNF-α Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-TNF-α Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-TNF-α Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-TNF-α Monoclonal Antibody include Abbive, Johnson and Johnson and UCB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-TNF-α Monoclonal Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-TNF-α Monoclonal Antibody market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-TNF-α Monoclonal Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-TNF-α Monoclonal Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-TNF-α Monoclonal Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-TNF-α Monoclonal Antibody Market by Company

Abbive

Johnson and Johnson

UCB

Anti-TNF-α Monoclonal Antibody Segment by Type

Infliximab

Pecerizumab

Golimumab

Adalimumab

Anti-TNF-α Monoclonal Antibody Segment by Application

Rheumatoid Arthritis

Ankylosing Spondylitis

Psoriasis

Other

Anti-TNF-α Monoclonal Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-TNF-α Monoclonal Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-TNF-α Monoclonal Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-TNF-α Monoclonal Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-TNF-α Monoclonal Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-TNF-α Monoclonal Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Infliximab Table 2. Major Company of Pecerizumab Table 3. Major Company of Golimumab Table 4. Major Company of Adalimumab Table 5. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (Kg) Table 7. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type (2021-2026) Table 8. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 9. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type (2021-2026) Table 10. Global Anti-TNF-α Monoclonal Antibody Price by Type (2021-2026) & (US$/Kg) Table 11. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2027-2032) & (Kg) Table 12. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type (2027-2032) Table 13. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2027-2032) & (US$ Million) Table 14. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type (2027-2032) Table 15. Global Anti-TNF-α Monoclonal Antibody Price by Type (2027-2032) & (US$/Kg) Table 16. North America Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (Kg) Table 17. North America Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (Kg) Table 19. Europe Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (Kg) Table 21. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (Kg) Table 23. Latin America Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (Kg) Table 25. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Type (2021-2026) & (US$ Million) Table 26. Anti-TNF-α Monoclonal Antibody Industry Trends Table 27. Anti-TNF-α Monoclonal Antibody Industry Drivers Table 28. Anti-TNF-α Monoclonal Antibody Industry Opportunities and Challenges Table 29. Anti-TNF-α Monoclonal Antibody Industry Restraints Table 30. Global Anti-TNF-α Monoclonal Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Company (2021-2026) Table 32. Global Anti-TNF-α Monoclonal Antibody Sales by Company (2021-2026) & (Kg) Table 33. Global Anti-TNF-α Monoclonal Antibody Sales Share by Company (2021-2026) Table 34. Global Anti-TNF-α Monoclonal Antibody Market Price by Company (2021-2026) & (US$/Kg) Table 35. Global Anti-TNF-α Monoclonal Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Anti-TNF-α Monoclonal Antibody Major Company Production Sites and Headquarters Table 37. Global Anti-TNF-α Monoclonal Antibody Company, Product Type & Application Table 38. Global Anti-TNF-α Monoclonal Antibody Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Anti-TNF-α Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Anti-TNF-α Monoclonal Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2021-2026) & (Kg) Table 43. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Region (2021-2026) Table 44. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2021-2026) & (US$ Million) Table 45. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Region (2021-2026) Table 46. Global Anti-TNF-α Monoclonal Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 47. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2027-2032) & (Kg) Table 48. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Region (2027-2032) Table 49. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2027-2032) & (US$ Million) Table 50. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Region (2027-2032) Table 51. Global Anti-TNF-α Monoclonal Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 52. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (Kg) Table 54. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application (2021-2026) Table 55. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 56. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application (2021-2026) Table 57. Global Anti-TNF-α Monoclonal Antibody Price by Application (2021-2026) & (US$/Kg) Table 58. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2027-2032) & (Kg) Table 59. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application (2027-2032) Table 60. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2027-2032) & (US$ Million) Table 61. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application (2027-2032) Table 62. Global Anti-TNF-α Monoclonal Antibody Price by Application (2027-2032) & (US$/Kg) Table 63. North America Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (Kg) Table 64. North America Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (Kg) Table 66. Europe Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (Kg) Table 68. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (Kg) Table 70. Latin America Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (Kg) Table 72. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Application (2021-2026) & (US$ Million) Table 73. Abbive Company Information Table 74. Abbive Business Overview Table 75. Abbive Anti-TNF-α Monoclonal Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Abbive Anti-TNF-α Monoclonal Antibody Product Portfolio Table 77. Abbive Recent Development Table 78. Johnson and Johnson Company Information Table 79. Johnson and Johnson Business Overview Table 80. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product Portfolio Table 82. Johnson and Johnson Recent Development Table 83. UCB Company Information Table 84. UCB Business Overview Table 85. UCB Anti-TNF-α Monoclonal Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. UCB Anti-TNF-α Monoclonal Antibody Product Portfolio Table 87. UCB Recent Development Table 88. North America Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 89. North America Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg) Table 90. North America Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 91. North America Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 92. North America Anti-TNF-α Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 93. North America Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Anti-TNF-α Monoclonal Antibody Market Share by Country (2021-2026) Table 96. North America Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Anti-TNF-α Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 98. Europe Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 99. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg) Table 100. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 101. Europe Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 102. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 103. Europe Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Anti-TNF-α Monoclonal Antibody Market Share by Country (2021-2026) Table 106. Europe Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Anti-TNF-α Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg) Table 110. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 111. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 112. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Share by Country (2021-2026) Table 116. Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 118. Latin America Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 119. Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg) Table 120. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 121. Latin America Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 122. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 123. Latin America Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Anti-TNF-α Monoclonal Antibody Market Share by Country (2021-2026) Table 126. Latin America Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Anti-TNF-α Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 128. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 129. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026) & (Kg) Table 130. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2021-2026) Table 131. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 132. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share Forecast by Country (2027-2032) Table 133. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Share by Country (2021-2026) Table 136. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Share Forecast by Country (2027-2032) Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Anti-TNF-α Monoclonal Antibody Distributors List Table 141. Anti-TNF-α Monoclonal Antibody Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Anti-TNF-α Monoclonal Antibody Image Figure 2. Global Anti-TNF-α Monoclonal Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-TNF-α Monoclonal Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-TNF-α Monoclonal Antibody Sales (2021-2032) & (Kg) Figure 5. Infliximab Image Figure 6. Global Infliximab Sales YoY Growth (2021-2032) & (Kg) Figure 7. Pecerizumab Image Figure 8. Global Pecerizumab Sales YoY Growth (2021-2032) & (Kg) Figure 9. Golimumab Image Figure 10. Global Golimumab Sales YoY Growth (2021-2032) & (Kg) Figure 11. Adalimumab Image Figure 12. Global Adalimumab Sales YoY Growth (2021-2032) & (Kg) Figure 13. Global Anti-TNF-α Monoclonal Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Anti-TNF-α Monoclonal Antibody Market Share by Type 2025 VS 2032 Figure 15. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 16. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 17. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 21. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Anti-TNF-α Monoclonal Antibody Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Rheumatoid Arthritis Image Figure 28. Global Rheumatoid Arthritis Sales YoY Growth (2021-2032) & (Kg) Figure 29. Ankylosing Spondylitis Image Figure 30. Global Ankylosing Spondylitis Sales YoY Growth (2021-2032) & (Kg) Figure 31. Psoriasis Image Figure 32. Global Psoriasis Sales YoY Growth (2021-2032) & (Kg) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (Kg) Figure 35. Global Anti-TNF-α Monoclonal Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Anti-TNF-α Monoclonal Antibody Market Share by Application 2025 VS 2032 Figure 37. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 38. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 39. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 43. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2025 Figure 47. North America Anti-TNF-α Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. North America Anti-TNF-α Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Anti-TNF-α Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-TNF-α Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Europe Anti-TNF-α Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Anti-TNF-α Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-TNF-α Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Latin America Anti-TNF-α Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Anti-TNF-α Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 64. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anti-TNF-α Monoclonal Antibody Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Anti-TNF-α Monoclonal Antibody Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Infliximab
  • Pecerizumab
  • Golimumab
  • Adalimumab
Applications
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Psoriasis
  • Other
Companies covered
  • Abbive
  • Johnson and Johnson
  • UCB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-TNF-α Monoclonal Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-TNF-α Monoclonal Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-TNF-α Monoclonal Antibody Market by Type
  6. 1.3.1 Infliximab
  7. 1.3.2 Pecerizumab
  8. 1.3.3 Golimumab
  9. 1.3.4 Adalimumab
  10. 1.4 Global Anti-TNF-α Monoclonal Antibody Market Size by Type
  11. 1.4.1 Global Anti-TNF-α Monoclonal Antibody Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Anti-TNF-α Monoclonal Antibody Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-TNF-α Monoclonal Antibody Industry Trends
  2. 2.2 Anti-TNF-α Monoclonal Antibody Industry Drivers
  3. 2.3 Anti-TNF-α Monoclonal Antibody Industry Opportunities and Challenges
  4. 2.4 Anti-TNF-α Monoclonal Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-TNF-α Monoclonal Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-TNF-α Monoclonal Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-TNF-α Monoclonal Antibody Price (2021-2026)
  4. 3.4 Global Anti-TNF-α Monoclonal Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-TNF-α Monoclonal Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-TNF-α Monoclonal Antibody Company, Product Type & Application
  7. 3.7 Global Anti-TNF-α Monoclonal Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-TNF-α Monoclonal Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-TNF-α Monoclonal Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-TNF-α Monoclonal Antibody Tier 1, Tier 2, and Tier 3
4 Anti-TNF-α Monoclonal Antibody Regional Status and Outlook
  1. 4.1 Global Anti-TNF-α Monoclonal Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-TNF-α Monoclonal Antibody Historic Market Size by Region
  3. 4.2.1 Global Anti-TNF-α Monoclonal Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-TNF-α Monoclonal Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-TNF-α Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Region
  7. 4.3.1 Global Anti-TNF-α Monoclonal Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-TNF-α Monoclonal Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-TNF-α Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-TNF-α Monoclonal Antibody by Application
  1. 5.1 Anti-TNF-α Monoclonal Antibody Market by Application
  2. 5.1.1 Rheumatoid Arthritis
  3. 5.1.2 Ankylosing Spondylitis
  4. 5.1.3 Psoriasis
  5. 5.1.4 Other
  6. 5.2 Global Anti-TNF-α Monoclonal Antibody Market Size by Application
  7. 5.2.1 Global Anti-TNF-α Monoclonal Antibody Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anti-TNF-α Monoclonal Antibody Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbive
  2. 6.1.1 Abbive Company Information
  3. 6.1.2 Abbive Business Overview
  4. 6.1.3 Abbive Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbive Anti-TNF-α Monoclonal Antibody Product Portfolio
  6. 6.1.5 Abbive Recent Developments
  7. 6.2 Johnson and Johnson
  8. 6.2.1 Johnson and Johnson Company Information
  9. 6.2.2 Johnson and Johnson Business Overview
  10. 6.2.3 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product Portfolio
  12. 6.2.5 Johnson and Johnson Recent Developments
  13. 6.3 UCB
  14. 6.3.1 UCB Company Information
  15. 6.3.2 UCB Business Overview
  16. 6.3.3 UCB Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 UCB Anti-TNF-α Monoclonal Antibody Product Portfolio
  18. 6.3.5 UCB Recent Developments
7 North America by Country
  1. 7.1 North America Anti-TNF-α Monoclonal Antibody Sales by Country
  2. 7.1.1 North America Anti-TNF-α Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-TNF-α Monoclonal Antibody Market Size by Country
  6. 7.2.1 North America Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-TNF-α Monoclonal Antibody Sales by Country
  2. 8.1.1 Europe Anti-TNF-α Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-TNF-α Monoclonal Antibody Market Size by Country
  6. 8.2.1 Europe Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Country
  2. 9.1.1 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-TNF-α Monoclonal Antibody Sales by Country
  2. 10.1.1 South America Anti-TNF-α Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-TNF-α Monoclonal Antibody Market Size by Country
  6. 10.2.1 South America Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country
  2. 11.1.1 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-TNF-α Monoclonal Antibody Value Chain Analysis
  2. 12.1.1 Anti-TNF-α Monoclonal Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-TNF-α Monoclonal Antibody Production Mode & Process
  7. 12.2 Anti-TNF-α Monoclonal Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-TNF-α Monoclonal Antibody Distributors
  10. 12.2.3 Anti-TNF-α Monoclonal Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst